The Latest Breaking News from Medpace

Don’t Chase Medpace Stock Here Despite Its Strong Technical Momentum

Medpace (MEDP) demonstrates strong technical momentum, maintaining a 100% “Buy” technical opinion from Barchart. Shares are up more than 20% over the past year. Valuation remains a concern, with a trailing P/E of 36.35x. I maintain a “Hold” stance, recommending existing holders use a stop loss due to high volatility...

Barchart · 11h ago

6 Healthcare Stocks With Strong Upward Momentum

Out with the old (tech), in with the new (healthcare). After several volatile weeks, it appears a full-fledged rotation has begun with investors fleeing previously high-flying tech winners in favor of underserved healthcare stocks.

Benzinga · Nov 18, 2025

Medpace Analysts Increase Their Forecasts After Upbeat Q3 Earnings

Medpace Holdings Inc. (NASDAQ:MEDP) posted better-than-expected third-quarter earnings on Thursday.

Benzinga · Oct 24, 2025

Coca-Cola, General Motors And 3 Stocks To Watch Heading Into Tuesday

With U.S. stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Benzinga · Jul 22, 2025

Medpace Holdings Stock Soars After Company Tops Q2 Earnings Estimates, Raises 2025 Outlook

Medpace Holdings Inc (NASDAQ:MEDP) shares are soaring in Monday’s after-hours session after the company reported strong financial results for the second quarter and raised its full-year guidance. Here’s what you need to know.

Benzinga · Jul 21, 2025

How execs cash in on competitors' stocks

CEOs make massive bets on the stocks of direct competitors and partners — and with exquisite timing

Salon · Mar 17, 2023

Medpace Posts Better Than Expected Q1 Earnings, Lifts FYY22 Profit Outlook

Medpace Holdings Inc's (NASDAQ:MEDP) Q1 revenue increased 27.3% Y/Y to $330.9 million, beating the consensus of $327.09 million. On a constant currency organic basis, revenue increased 28.1%. As of March 31, 2022, the Backlog grew 28% to $2.1 billion. Net new business awards were $423 million, representing a net book-to-bill ratio of…

Benzinga · Apr 26, 2022

Medpace Reports Mixed Q4 Earnings, Issues FY22 Guidance Ahead Of Estimates

Medpace Holdings Inc's (NASDAQ: MEDP) 

Benzinga · Feb 15, 2022